Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of the frontal aslant tract and implications for primate vocalization and human speech.

Nature communications·2026
Same author

DECODE: An innovative tool to aid cross-linguistic neuropsychological assessment.

The Clinical neuropsychologist·2026
Same author

Graphic transmutations identify the phenomenon of meaningless pictures remembered as familiar objects.

Scientific reports·2026
Same author

Bekhterev's case: Amnesia due to bi-hippocampal damage 50 years before HM.

Cortex; a journal devoted to the study of the nervous system and behavior·2025
Same author

Internal structure of the prospective and retrospective memory questionnaire - PRMQ - in a sample of 297,242 participants.

Memory (Hove, England)·2025
Same author

CBT for psychosis in Parkinson's disease: A framework for how and why.

Schizophrenia research·2025
Same journal

Correction to "MST1 Suppression Reduces Early Brain Injury by Inhibiting the NF-κB/MMP-9 Pathway after Subarachnoid Hemorrhage in Mice".

Behavioural neurology·2026
Same journal

Social Determinants of Health and Their Association With Parkinson's Disease Prevalence in US Adults: Insights From NHANES 2001-2020.

Behavioural neurology·2026
Same journal

GLP-1 Agonist Attenuates Nicotine Reward-Related Behavior by Regulating the Prepro-Orexin in the Hypothalamus and Prepro-Glucagon in the Nucleus Tractus Solitarius.

Behavioural neurology·2026
Same journal

Using Virtual Reality to Complement Paper-and-Pencil Tests to Assess Visual Unilateral Spatial Neglect: A Feasibility Study.

Behavioural neurology·2026
Same journal

Adverse Childhood Experiences Underlie Race-Related Differences in Neural Reactivity to Stress.

Behavioural neurology·2026
Same journal

The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson's Disease Severity.

Behavioural neurology·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Dual task performance in Parkinson's disease.

Jennifer A Foley1, Reiner Kaschel, Sergio Della Sala

  • 1Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. jfoley@ed.ac.uk

Behavioural Neurology
|December 18, 2012
PubMed
Summary
This summary is machine-generated.

Dual tasking, the ability to perform two tasks simultaneously, is impaired in Alzheimer's disease (AD) but not Parkinson's disease (PD). This study found the dual task deficit to be specific to AD, worsening with disease severity.

More Related Videos

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

Related Experiment Videos

Last Updated: May 16, 2026

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Gerontology

Background:

  • Dual tasking is known to be impaired in Alzheimer's disease (AD).
  • It is unclear if this impairment is specific to AD or also affects other neurodegenerative conditions like Parkinson's disease (PD).
  • Understanding task-specific deficits aids in differential diagnosis and understanding disease mechanisms.

Purpose of the Study:

  • To investigate whether the dual task deficit observed in Alzheimer's disease is specific to AD.
  • To compare the dual tasking abilities of individuals with Parkinson's disease to those with Alzheimer's disease and healthy controls.

Main Methods:

  • A comparative study design was employed.
  • Participants included individuals with Parkinson's disease (PD), Alzheimer's disease (AD), and age-matched healthy controls.
  • Dual tasking performance was assessed and compared across the three groups.

Main Results:

  • Individuals with Alzheimer's disease (AD) showed a specific impairment in dual tasking.
  • The severity of the dual task deficit in AD correlated with disease progression.
  • Individuals with Parkinson's disease (PD) did not exhibit significant dual tasking deficits compared to healthy controls.

Conclusions:

  • The dual task impairment is specific to Alzheimer's disease (AD), not a general feature of neurodegenerative disorders affecting older adults.
  • These findings highlight the potential of dual tasking assessment as a tool for differentiating AD from PD.
  • Further research can explore the neural underpinnings of this specific dual task deficit in AD.